1
|
Thale I, Naß E, Vinnenberg L, Todesca LM, Budde T, Maisuls I, Strassert CA, Schwab A, Wünsch B. Fluorescent Probes to Image the K Ca3.1 Channel in Tumor Cells. Pharmaceutics 2025; 17:154. [PMID: 40006521 PMCID: PMC11859423 DOI: 10.3390/pharmaceutics17020154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2024] [Revised: 01/15/2025] [Accepted: 01/20/2025] [Indexed: 02/27/2025] Open
Abstract
Background/Objectives: The Ca2+-activated K+ channel KCa3.1 is not only involved in physiological processes such as immune reactions and control of vascular tone, but is highly expressed in various tumor entities. Thus, imaging of KCa3.1 channels comes into focus for the localization of high channel density, i.e., for tumor diagnosis. In particular, the physicochemical properties of the fluorescent probes should be improved compared to existing probes. Methods: The small molecule inhibitor of the KCa3.1 channel, senicapoc, was used as a warhead and was coupled with different fluorescent dyes. After synthesis of the novel probes, their physicochemical properties (lipophilicity, photophysical properties) and their ability to image KCa3.1 channels in A549-3R lung tumor cells were determined. Results: In order to increase the polarity and quantum yield of reported fluorescent probes, three strategies were followed: (1) An F-atom at the B-atom of bodipy-labeled senicapoc derivatives 9a, 9b, and 15a was replaced by a OCH3 moiety, which decreased the logP value by one log-unit. (2) The p-phenylene moiety of the linker was replaced by an aliphatic tetramethylene linker decreasing the lipophilicity by 0.3-0.5 log-units. (3) Instead of bodipy dyes, fluorescein was coupled with the senicapoc warhead resulting in very polar probes 21a and 21b with low logP values of 1.5 and 1.3, respectively. Introduction of an ethyl moiety at the bodipy core increased the quantum yield, which resulted in the best punctate staining pattern of fixed and living A549-3R lung tumor cells with the ethylbodipy-labeled senicapoc derivative 10b. The specificity was shown by various control experiments. Co-staining with 10b and an antibody did not result in overlapping signals. Conclusions: The well-balanced lipophilicity and fluorescent quantum yield render the ethylbodipy-labeled senicapoc derivative 10b a very good probe to image selectively KCa3.1 ion channels in fixed and living tumor cells. It was hypothesized that the antibody binds selectively at the closed channel (58.5%), whereas the senicapoc-bodipy conjugate 10b binds selectively at the open channel (41.5%). The ratio 58.5:41.5 reflects the ratio of the ion channel in closed and open conformations.
Collapse
Affiliation(s)
- Insa Thale
- Chemical Biology of Ion Channels (Chembion), University of Münster, Corrensstraße 48, D-48149 Münster, Germany; (I.T.); (L.V.); (L.M.T.); (T.B.); (A.S.)
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstraße 48, D-48149 Münster, Germany
| | - Elke Naß
- Institute of Physiology I, University of Münster, University Hospital Münster, Robert-Koch-Straße 27a, D-48149 Münster, Germany;
| | - Laura Vinnenberg
- Chemical Biology of Ion Channels (Chembion), University of Münster, Corrensstraße 48, D-48149 Münster, Germany; (I.T.); (L.V.); (L.M.T.); (T.B.); (A.S.)
- Institute of Physiology I, University of Münster, University Hospital Münster, Robert-Koch-Straße 27a, D-48149 Münster, Germany;
| | - Luca Matteo Todesca
- Chemical Biology of Ion Channels (Chembion), University of Münster, Corrensstraße 48, D-48149 Münster, Germany; (I.T.); (L.V.); (L.M.T.); (T.B.); (A.S.)
- Institute of Physiology II, University of Münster, University Hospital Münster, Robert-Koch-Straße 27b, D-48149 Münster, Germany
- Department of Biology, University of Padua, Via U.Bassi 58/B, 35131 Padova, Italy
| | - Thomas Budde
- Chemical Biology of Ion Channels (Chembion), University of Münster, Corrensstraße 48, D-48149 Münster, Germany; (I.T.); (L.V.); (L.M.T.); (T.B.); (A.S.)
- Institute of Physiology I, University of Münster, University Hospital Münster, Robert-Koch-Straße 27a, D-48149 Münster, Germany;
| | - Ivan Maisuls
- Institute of Inorganic and Analytical Chemistry, University of Münster, CiMIC, SoN, Corrensstraße 28, D-48149 Münster, Germany; (I.M.); (C.A.S.)
- CeNTech, University of Münster, Heisenbergstraße 11, D-48149 Münster, Germany
| | - Cristian A. Strassert
- Institute of Inorganic and Analytical Chemistry, University of Münster, CiMIC, SoN, Corrensstraße 28, D-48149 Münster, Germany; (I.M.); (C.A.S.)
- CeNTech, University of Münster, Heisenbergstraße 11, D-48149 Münster, Germany
| | - Albrecht Schwab
- Chemical Biology of Ion Channels (Chembion), University of Münster, Corrensstraße 48, D-48149 Münster, Germany; (I.T.); (L.V.); (L.M.T.); (T.B.); (A.S.)
- Institute of Physiology II, University of Münster, University Hospital Münster, Robert-Koch-Straße 27b, D-48149 Münster, Germany
| | - Bernhard Wünsch
- Chemical Biology of Ion Channels (Chembion), University of Münster, Corrensstraße 48, D-48149 Münster, Germany; (I.T.); (L.V.); (L.M.T.); (T.B.); (A.S.)
- Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstraße 48, D-48149 Münster, Germany
| |
Collapse
|
3
|
Ackermann TM, Höfner G, Wanner KT. Screening for New Inhibitors of Glycine Transporter 1 and 2 by Means of MS Binding Assays. ChemMedChem 2021; 16:3094-3104. [PMID: 34174033 PMCID: PMC8518836 DOI: 10.1002/cmdc.202100408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2021] [Indexed: 11/10/2022]
Abstract
A straightforward screening of a compound library comprising 2439 substances for the identification of new inhibitors for the neurotransmitter transporters GlyT1 and GlyT2 is described. Screening and full-scale competition experiments were performed using recently developed GlyT1 and GlyT2 MS Binding Assays. That way for both targets, GlyT1 and GlyT2, ligands were identified, which exhibited affinities (pKi values) in the low micromolar to sub-micromolar range. The majority of these binders exhibit new chemical scaffolds in the class of GlyT1 and GlyT2 inhibitors, which could be of interest for the development of new ligands with improved affinities for the target proteins. Additionally, compounds with excellent fluorescent properties were found for GlyT2, which renders them promising compounds for future fluorescence-based techniques. All in all, this study demonstrates that MS Binding Assays represent a powerful technology platform also well suited for the screening of compound libraries in a highly reliable and effective manner.
Collapse
Affiliation(s)
- Thomas M. Ackermann
- Department of Pharmacy – Center for Drug ResearchLudwig-Maximilians-Universität MunichButenandtstraße 781377MunichGermany
| | - Georg Höfner
- Department of Pharmacy – Center for Drug ResearchLudwig-Maximilians-Universität MunichButenandtstraße 781377MunichGermany
| | - Klaus T. Wanner
- Department of Pharmacy – Center for Drug ResearchLudwig-Maximilians-Universität MunichButenandtstraße 781377MunichGermany
| |
Collapse
|